The Latest Breaking News from NYSE

What 5 Analyst Ratings Have To Say About Boston Scientific

Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Feb 3, 2022

Earnings Outlook For Bristol-Myers Squibb

Bristol-Myers Squibb (NYSE:BMY) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Bristol-Myers Squibb will likely report an Earnings Per Share (EPS) of $1.80.

Benzinga · Feb 3, 2022

Expert Ratings For Humana

Analysts have provided the following ratings for Humana (NYSE:HUM) within the last quarter:

Benzinga · Feb 3, 2022

Cummins: Q4 Earnings Insights

  Cummins (NYSE:CMI) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 3, 2022

Schneider National: Q4 Earnings Insights

  Schneider National (NYSE:SNDR) reported its Q4 earnings results on Thursday, February 3, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 3, 2022

Recap: BBVA Q4 Earnings

  BBVA (NYSE:BBVA) reported its Q4 earnings results on Thursday, February 3, 2022 at 03:30 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 3, 2022

CMS Energy: Q4 Earnings Insights

  CMS Energy (NYSE:CMS) reported its Q4 earnings results on Thursday, February 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 3, 2022

What Does Leggett & Platt's Debt Look Like?

Shares of Leggett & Platt (NYSE:LEG) moved lower by 10.65% in the past three months. Before we understand the importance of debt, let us look at how much debt Leggett & Platt has.

Benzinga · Feb 3, 2022

Regis's Return On Capital Employed Overview

According to Benzinga Pro data, during Q2, Regis (NYSE:RGS) posted sales of $70.26 million. Earnings were up 52.51%, but Regis still reported an overall loss of $4.93 million.

Benzinga · Feb 3, 2022

DXC Technology Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q3, DXC Technology (NYSE:DXC) earned $102.00 million, a 154.55% increase from the preceding quarter. DXC Technology also posted a total of $4.09 billion in sales, a 1.54% increase since Q2.

Benzinga · Feb 3, 2022